SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEbiquity Regulatory News (EBQ)

Share Price Information for Ebiquity (EBQ)

Share Price is delayed by 15 minutes
Get Live Data
10.75    0.00 (0.00%)
Bid:
10.50
Ask:
11.00
Spread: 0.50 (4.762%)
Market Cap: £14.94m
EBQ Live PriceLast checked at - London Stock Exchange

Intraday Ebiquity Share Chart

Trading Update

22 Nov 2018 07:00

RNS Number : 1435I
Ebiquity PLC
22 November 2018
 

Ebiquity Plc

 

Trading Update

 

 

Ebiquity plc ("Ebiquity"), a leading independent marketing and media consultancy, provides a trading update in relation to the financial year to 31 December 2018.

 

At Group level, Ebiquity anticipates organic revenue growth of circa 2%. However, the previously reported slowdown in the Advertising Intelligence practice, coupled with continued underperformance of the US Digital Analytics practice (for which actions have been taken) and delays in closing recent Media practice opportunities in Germany will result in operating profit being materially below current market expectations. With today's announcement of the CMA's final clearance of the sale of the Advertising Intelligence business, the Group's net debt position will be materially improved following the receipt of sale proceeds now anticipated to be around the end of the year.

 

Despite the revenue delays in Germany and challenges in the US Digital Analytics practice, the Media, Analytics and Tech practices (being the retained business following the disposal of the Advertising Intelligence business) continue to make strong progress in most territories, with overall revenue growth in line with expectations at circa 8% with particularly encouraging performances in the UK & Ireland and French markets. Encouraging new business wins in H2 include a global multi-year assignment across VW Group and the appointment as a global analytics partner to Nestle. Overall however, at an operating profit level, continued investment in these practices will mean profits are anticipated being below expectations.

 

The Advertising Intelligence practice continued to underperform in the year, given the ongoing uncertainties around the proposed disposal. This lengthy process required a considerable amount of management time and attention. The completion of this transaction will simplify the Group allowing it to focus on growing its core Media, Analytics and Tech practices going forward.

 

22 November 2018

Enquiries:

 

Ebiquity plc

Michael Karg (CEO)

Kevin McNair (Interim CFO)

 

020 7650 9600

 

Instinctif Partners

Matthew Smallwood

Guy Scarborough

020 7457 2020

 

Numis Securities Limited

Nick Westlake (NOMAD)

Michael Wharton

 

020 7260 1000

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTDDBDBIUDBGIB
Date   Source Headline
9th Sep 20167:00 amRNSAppointment of CFO and Director
6th Sep 20167:00 amRNSLaunch of new Advertising Intelligence platform
27th Jul 20167:00 amRNSTrading Statement
19th Jul 20167:30 amRNSGuidelines for achieving media transparency
19th Jul 20167:00 amRNSRe: Directorate
12th Jul 201611:45 amRNSTR-1: Notification of Major Interest in Shares
22nd Jun 201611:05 amRNSTR1
9th Jun 20161:50 pmRNSCapital Reduction effective
8th Jun 201611:40 amRNSCourt confirmation of Capital Reduction
3rd Jun 20163:50 pmRNSDirector dealing
20th May 20167:00 amRNSHolding(s) in Company
19th May 20162:25 pmRNSHolding(s) in Company
11th May 201611:20 amRNSAGM resolutions passed
11th May 20168:50 amRNSExercise of Share Options
29th Apr 20165:30 pmRNSRe Directorate
25th Apr 201610:45 amRNSHolding(s) in Company
15th Apr 20163:40 pmRNSAnnual Report
30th Mar 20167:00 amRNSFinal Results
27th Jan 20167:00 amRNSAppointment of Director and Director Dealing
27th Jan 20167:00 amRNSInterim Results
8th Jan 201611:27 amRNSHolding(s) in Company
26th Nov 20157:00 amRNSTrading Statement
25th Nov 20152:41 pmRNSDirector Dealing
9th Nov 201512:15 pmRNSCORRECTION - Holding(s) in Company
9th Nov 201510:21 amRNSHolding(s) in Company
6th Nov 201511:53 amRNSHolding(s) in Company
15th Oct 20157:10 amRNSExercise of Share Options
15th Oct 20157:00 amRNSAppointment of director
12th Oct 20152:21 pmRNSDirector Dealing
2nd Oct 20157:00 amRNSDirector Dealings
1st Oct 20157:00 amRNSBoard changes
22nd Sep 20154:48 pmRNSExercise of Share Options
17th Sep 20157:00 amRNSFinal dividend for the year ended 30 April 2015
15th Sep 20153:33 pmRNSResult of AGM
17th Aug 20157:00 amRNSAnnual Financial Report
28th Jul 20157:10 amRNSChange in financial year end
28th Jul 20157:00 amRNSFinal Results
6th Jul 20155:56 pmRNSHolding(s) in Company
25th Jun 201512:15 pmRNSHolding(s) in Company
24th Jun 20154:22 pmRNSHolding(s) in Company
24th Jun 20157:00 amRNSChange to final results announcement date
9th Jun 20154:13 pmRNSHolding(s) in Company
8th Jun 20152:43 pmRNSHolding(s) in Company
8th Jun 201511:10 amRNSHolding(s) in Company
1st Jun 201510:37 amRNSExercise of Share Options
27th May 20157:00 amRNSExercise of Share Options
27th May 20157:00 amRNSPre-close Trading Statement
22nd May 20155:15 pmRNSHolding(s) in Company
19th May 20157:00 amRNSExercise of Share Options
16th Mar 20154:30 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.